BB Biotech AG/Fr. BION
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About BB Biotech AG
BB Biotech AG is an investment company that focuses on biotechnology firms, primarily investing in the equity of publically traded companies within the biotech sector. Founded in 1993 and headquartered in Schaffhausen, Switzerland, BB Biotech is known for its strategic focus on innovation-driven companies that develop and market drugs with potential therapeutic benefits. It maintains a diversified portfolio, emphasizing products addressing unmet medical needs in areas such as oncology, neurology, and rare diseases. Its investment strategy leverages in-depth industry expertise to identify companies with promising product pipelines and strong management teams. The company holds stakes in multiple US and European biotechnology companies, reflecting its broad geographic reach.
Ticker
Fr. BION
Sector
Primary listing
XSWX
Employees
10
Headquarters
Küsnacht, Switzerland
BB Biotech AG Metrics
BasicAdvanced
CHF 2.3bn
2.89
CHF 14.51
0.63
CHF 2.25
5.36%
Price and volume
Market cap
CHF 2.3bn
Beta
0.63
52-week high
CHF 49.65
52-week low
CHF 29.00
Average daily volume
73k
Dividend rate
CHF 2.25
Financial strength
Current ratio
336.028
Quick ratio
335.836
Dividend payout ratio (TTM)
15.56%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
129.31%
Operating margin (TTM)
94.47%
Effective tax rate (TTM)
0.01%
Revenue per employee (TTM)
CHF 61,690,000
Management effectiveness
Return on assets (TTM)
15.87%
Return on equity (TTM)
34.85%
Valuation
Price to earnings (TTM)
2.894
Price to revenue (TTM)
3.741
Price to book
0.88
Price to tangible book (TTM)
0.88
Price to free cash flow (TTM)
5.862
Free cash flow yield (TTM)
17.06%
Free cash flow per share (TTM)
7.165
Dividend yield (TTM)
5.36%
Forward dividend yield
5.36%
Growth
Revenue change (TTM)
-860.00%
Earnings per share change (TTM)
-286.53%
3-year revenue growth (CAGR)
5,262.66%
10-year revenue growth (CAGR)
8.80%
3-year earnings per share growth (CAGR)
36.72%
10-year earnings per share growth (CAGR)
-1.44%
3-year dividend per share growth (CAGR)
-7.58%
10-year dividend per share growth (CAGR)
-2.51%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs